about
Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial.The use of gas chromatography to analyze compositional changes of fatty acids in rat liver tissue during pregnancy.Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans.The Pattern of Fatty Acids Displaced by EPA and DHA Following 12 Months Supplementation Varies between Blood Cell and Plasma Fractions.Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish.Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastasesPerioperative immunonutrition in well-nourished patients undergoing surgery for head and neck cancer: evaluation of inflammatory and immunologic outcomesAcute appearance of fatty acids in human plasma--a comparative study between polar-lipid rich oil from the microalgae Nannochloropsis oculata and krill oil in healthy young malesCompared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans.Omega-3 fatty acids do not alter P-wave parameters in electrocardiogram or expression of atrial connexins in patients undergoing coronary artery bypass surgery.Membrane fatty acids, oxidative burst and phagocytosis after enrichment of P388D1 monocyte/macrophages with essential 18-carbon fatty acids.Fatty acid profile of plasma NEFA does not reflect adipose tissue fatty acid profile.Lipid structure does not modify incorporation of EPA and DHA into blood lipids in healthy adults: a randomised-controlled trial.Lipidomics Profiling of Human Adipose Tissue Identifies a Pattern of Lipids Associated with Fish Oil Supplementation.Impairment of lysophospholipid metabolism in obesity: altered plasma profile and desensitization to the modulatory properties of n-3 polyunsaturated fatty acids in a randomized controlled trial.Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trialUnsaturated fatty acids differ between hepatic colorectal metastases and liver tissue without tumour in humans: Results from a randomised controlled trial of intravenous eicosapentaenoic and docosahexaenoic acidsThe effect of altering the 20:5n-3 and 22:6n-3 content of a meal on the postprandial incorporation of n-3 polyunsaturated fatty acids into plasma triacylglycerol and non-esterified fatty acids in humansEffect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN StudyFish oil supplementation decreases oxidative stress but does not affect platelet-activating factor bioactivity in lungs of asthmatic ratsPlasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humansA Novel Self-Micro-Emulsifying Delivery System Enhances Enrichment of Eicosapentaenoic Acid and Docosahexaenoic Acid after Single and Repeated Dosing in Healthy Adults in a Randomized TrialPostprandial incorporation of EPA and DHA from transgenic Camelina sativa oil into blood lipids is equivalent to that from fish oil in healthy humans
P50
Q30642691-D9CD1D11-25ED-45B6-BA85-9FF7E0B87049Q34118041-D48EA1A6-D883-499E-A57A-B7A330EC5AA0Q35154387-A272DB4F-5833-4A1A-9EFB-C9A6934F2B3FQ36012359-E82FC6F4-A476-47E7-B28C-58F86AC8F046Q36231619-A43268B2-F0C3-4F72-A68F-5A04D06340C8Q36859103-00FB93BB-73DD-4D1C-BDBB-BDBE0E3C7238Q36994065-E311BAD8-6D0A-4308-855C-67DFC51CA1A3Q37033572-C5A076D0-38BF-4A0E-808D-8E52DB70931BQ37701518-F58D084B-1958-4528-A91D-05690625EA40Q40018992-1FCF4E4E-FD24-4A21-B570-C05BEE46107DQ40126415-079474C3-C4AB-4050-B5C4-BE806D7A202CQ40702150-563E6FF1-F7D1-489A-80B0-5F797DCED483Q48156441-1625B514-1C74-4F8D-86B1-79BD4FFD3B1FQ48319721-ED69D860-954E-4B59-B7B3-F373812FEDC1Q51283185-F7BE9865-3397-4639-B3D9-51E3F989F9A8Q60408831-89655E18-506F-4820-A0DF-9668FBC450C0Q60754104-849F1D49-BB81-4ADB-A7A2-5A49E58B7890Q80784205-A8D35FC6-9C6B-41BD-A728-E771C21A6900Q81943023-5E209D60-491E-4B2C-9E82-ED85C907F32FQ87945200-C8195051-3F8D-4A3D-8C45-C7C0019552BDQ90043134-44BB2784-E81C-4F45-AF73-72338C4EC63EQ91375160-05DED070-6468-4F9B-821D-BD7FD4A4EDDDQ93035873-45CC749A-96C4-4C2C-94EA-D20F46777DE3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Annette L West
@ast
Annette L West
@en
Annette L West
@es
Annette L West
@nl
type
label
Annette L West
@ast
Annette L West
@en
Annette L West
@es
Annette L West
@nl
prefLabel
Annette L West
@ast
Annette L West
@en
Annette L West
@es
Annette L West
@nl
P106
P31
P496
0000-0002-3331-0684